Cargando…
Prolonged treatment with recombinant interferon gamma induces erythema nodosum leprosum in lepromatous leprosy patients
10 patients with borderline and lepromatous leprosy were selected for a prolonged trial with recombinant interferon gamma (rIFN-gamma). Patients received 30 micrograms intradermally for six injections over a 9-d period, and then either 100 micrograms intradermally every 1 mo for 10 mo or every 2 wk...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1992
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2119233/ https://www.ncbi.nlm.nih.gov/pubmed/1588290 |
Ejemplares similares
-
A Case of Lepromatous Leprosy With Erythema Nodosum Leprosum
por: Park, Lily, et al.
Publicado: (2023) -
Erythema nodosum leprosum after allergen immunotherapy as initial presentation of lepromatous leprosy treated with novel multidrug regimen
por: Xie, Catherine B., et al.
Publicado: (2023) -
Etanercept in erythema nodosum leprosum
por: Santos, Julia Rocha Silva, et al.
Publicado: (2017) -
T-cell regulation in Erythema Nodosum Leprosum
por: Negera, Edessa, et al.
Publicado: (2017) -
Lichenoid Skin Nodules as Presenting Feature of Necrotic Erythema Nodosum Leprosum in Leprosy
por: Kaushik, Akanksha, et al.
Publicado: (2020)